NCRI 2018 | Head and neck cancer challenges & cetuximab trial updates

Quynh-Thu Le

The treatment of head and neck cancer comes with many challenges, as discussed here by Quynh-Thu Le, MD, from Stanford University, Stanford, CA, at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK. Prof. Le highlights the key obstacles in this field, and discusses two current trials investigating cetuximab. This video was recorded at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.

Share this video